<DOC>
	<DOCNO>NCT02670070</DOCNO>
	<brief_summary>This study evaluate safety/tolerability pharmacokinetics combination gemigliptin 50mg rosuvastatin 20mg comparison component administer alone healthy male volunteer .</brief_summary>
	<brief_title>BE Study Combinations Gemigliptin 50mg Rosuvastatin 20mg Comparison Each Component Administered Alone</brief_title>
	<detailed_description>This study evaluate safety/tolerability pharmacokinetics ( AUC Cmax ) combination gemigliptin 50mg rosuvastatin 20mg comparison component administer alone healthy male volunteer .</detailed_description>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Age 19 45 , healthy male subject ( screen ) BMI 18.0 27.0 FPG 70125mg/dL glucose level ( screen ) Subject totally understand progress clinical trial , make decision free , signed consent form follow progress . Subject past present history disease follow . ( liver include hepatitis virus carrier , kidney , Neurology , immunology , pulmonary , endocrine , hematooncology , cardiology , mental disorder . ) Subject GI tract disease ( ulcer , acute chronic pancreatitis ) surgery . ( appendectomy , hernioplasty include ) Subject drug hypersensitivity reaction . ( Aspirin , antibiotic ) Subject already participate trial 2months Subject whole blood donation 2 month , component blood donation 1 month transfusion 1 month currently . Heavy smoker . ( &gt; 10 cigarette per day )</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>